KENNETH WALLACE: Open Payments
NPI 1295791754 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,107 in 19 payments from 8 companies in 2025. Trend: 2023 $1,113 · 2024 $2,835 · 2025 $22,107
Debt forgiveness: $21,482Food & beverage: $625
| Company | Payments | Amount |
|---|---|---|
| Biofrontera Inc. | 1 | $21,482 |
| STRATA Skin Sciences, Inc. | 4 | $168 |
| Janssen Biotech, Inc. | 1 | $146 |
| ABBVIE INC. | 5 | $107 |
| Regeneron Healthcare Solutions, Inc. | 3 | $75 |
| GENZYME CORPORATION | 2 | $71 |
| Kerecis Limited | 2 | $39 |
| ConvaTec Inc. | 1 | $18 |
Products named: AMELUZ, XTRAC, TREMFYA, DUPIXENT, SKYRIZI, Kerecis SurgiClose, RINVOQ, INNOVABURN.
Industry payments across FL — which companies pay providers there.
